Skip to main content

Table 2 Baseline characteristics of enrolled participants by sitea

From: Recruitment of high risk women for HIV prevention trials: baseline HIV prevalence and sexual behavior in the CAPRISA 004 tenofovir gel trial

Variable

Variable category

Overall

Rural (FP)

Urban (STD)

P value

  

N = 889

n = 611

n = 278

 

Sociodemographic characteristics

Age (Mean; ± SD; range)

23.9; ± 5.1; 18-40

23.3; ± 4.9; 18-40

25.1; ± 5.4;18-39

<0.001

Parity (Mean; ± SD; range)

1.1 (0-8)

1.1 (0-5)

1.4 (0-8)

<0.001

Age groups (n, %)

    
 

18 to 24 years

579 (65.1)

423 (69.2)

156 (56.1)

0.001

 

25 to 29 years

177 (19.9)

112 (18.3)

65 (23.4)

 
 

30 to 34 years

85 (9.6)

52 (8.5)

33 (11.9)

 
 

35 to 40 years

48 (5.4)

24 (3.9)

24 (8.6)

 

Education level (n, %)

    
 

No Schooling

4 (0.4)

4 (0.7)

0 (0)

<0.001

 

Primary school

37 (4.2)

25 (4.1)

12 (4.3)

 
 

High school not complete

483 (54.3)

377 (61.7)

106 (38.1)

 
 

High school complete

301 (33.9)

195 (31.9)

106 (38.1)

 
 

Some Tertiary education

64 (7.2)

10 (1.6)

54 (19.4)

 

Income level (n, %)

    
 

No income

96 (10.9)

78 (12.8)

18 (6.5)

<0.001

 

<R1000 per month

718 (80.7)

526 (86.1)

192 (69.1)

 
 

>R1001 per month

75 (8.4)

7 (1.1)

68 (24.5)

 

Contraception (n, %)

    
 

Hormonal injectables

730 (82.1)

508 (83.1)

222 (79.9)

0.58

 

Hormonal oral

138 (15.5)

89 (14.6)

49 (17.6)

 
 

Tubal ligation

20 (2.2)

13 (2.1)

7 (2.5)

 
 

Hysterectomy

1 (0.1)

1 (0.2)

0 (0)

 

Sexual behavioral characteristics

Age at sexual debut (Mean, ± SD, range)

17.4; ± 2.0; 12-26

17.3; ± 2.0; 12-25

17.7; ± 2.0; 12-26

0.01

Total lifetime sex partners (Mean, ± SD, range)

3.3; ± 10.5; 1-202

2.1; ± 1.2; 1-10

6.0; ± 18.4; 1-202

0.001

Sex acts in the past 7 days (Mean, ± SD, range)

2.0; ± 3.0; 0-40

1.7; ± 2.1; 0-28

2.7; ± 4.2;;0-40

<0.001

Sex acts in the past 30 days (Mean, ± SD, range)

8.4; ± 9.1; 0-130

6.7; ± 5.2; 0-40

12.1; ± 13.6;0-130

<0.001

Any anal sex in the past 30 days (n, %)

4 (0.5)

3 (0.5)

1 (0.4)

1.0

One stable sex partner in the past year (n, %)

846 (95.2)

588 (96.2)

258 (92.8)

0.04

One stable sex partner In the past 30 days (n, %)

855 (96.2)

590 (96.6)

265 (95.3)

0.45

Living with regular partner (n, %)

109 (12.3)

58 (9.5)

51 (18.3)

<0.001

New sex partner in the last 30 days (n, %)

10 (1.1)

3 (0.5)

7 (2.5)

0.01

More than 2 casual sex partners in the past year (n, %)

38 (4.3)

4 (0.7)

34 (12.2)

<0.001

Work requires sleeping overnight away from regular partner (n, %) b

214 (24.1)

169 (27.7)

45 (16.4)

<0.001

Nights sleeping away from partner in the last 30 days (Mean, ± SD, range)

22.4; ± 8.3; 0-30

24.6; ± 5.9; 0-30

17.3; ± 10.5; 0-30

<0.001

Ever forced to have sex with anyone (n, %)

6 (0.7)

1 (0.2)

5 (1.8)

0.01

Ever received money in exchange for sex (n, %)

17 (1.9)

2 (0.3)

15 (5.4)

<0.001

Knows sex partner has other sex partners in the last 30 days (n, %)

179 (20.1)

115 (18.8)

64 (23.0)

0.21

Knows sex partner had an HIV test in the last 30 days (n, %)

19 (2.1)

16 (2.6)

3 (1.1)

0.09

Alcohol usually consumed by partner before sex (n, %)

262 (29.5)

162 (26.5)

100 (36.0)

0.01

Alcohol consumed by partner and self before last sex (n, %)

36 (4.0)

4 (0.7)

32 (11.5)

<0.001

Male condoms use (n, %)

    
 

Always

259 (29.1)

140 (22.9)

119 (42.8)

<0.001

 

Sometimes

482 (54.2)

342 (56.0)

140 (50.4)

 
 

Never

148 (16.7)

129 (21.1)

19 (6.8)

 

Clinical characteristics

Genital symptoms$ in the last 30 days (n, %)

     
 

Any symptoms

335 (37.8)

189 (30.9)

146 (52.5)

<0.001

HSV-2 prevalence

454 (51.4) d

289 (47.6) c

165 (59.6) b

0.001

  1. a Parts of the data reported in Table 2 have previously been reported [22]b1 observation missing c 4 observations missing d 5 observations missing - Missing values were excluded from percentage calculation $ Genital symptoms of vaginal burning, pruritis, pain after sex, intermenstrual bleeding or burning and frequency when urinating or abnormal vaginal discharge or genital ulceration